<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="109422">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02114164</url>
  </required_header>
  <id_info>
    <org_study_id>OH1-13-00489</org_study_id>
    <nct_id>NCT02114164</nct_id>
  </id_info>
  <brief_title>Study of CO2 Exchange Patterns During Robotic Prostatectomies</brief_title>
  <official_title>A Comparative Study of CO2 Exchange Patterns Between Valve-free Trocar (AirSeal®) Versus Standard Trocar (Endopath®) During Robotic Prostatectomies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>OhioHealth</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Surgiquest</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>OhioHealth</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The AirSeal® System will allow for lower CO2 absorption rates than the Xcel® System.
      Furthermore, lower variance in pneumoperitoneal pressure will allow for less &quot;over-pressure&quot;
      events and peritoneal stretch, which may reduce postoperative pain.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary observation to be made is the level of PaCO2 in the arterial blood, specifically
      when the patient is insufflated and deflated during the surgery.  As a result of the
      consistent pressure that the AirSeal® system maintains, CO2 will be absorbed in lower levels
      when compared to the standard of care systems in which fluctuations in intra-peritoneum
      pressure are seen.  Therefore, higher pressures will result in higher levels of CO2 exchange
      in the blood, leading to increased vasodilation and lower pH levels.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Anticipated">June 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Intraoperative pneumoperitoneal pressure (mmHg).</measure>
    <time_frame>Through Day 1 post-op</time_frame>
    <safety_issue>No</safety_issue>
    <description>Compare the maximum intraoperative pneumoperitoneal pressure (mmHg), smoke evacuation quality (categorical), and overall operative times (minutes) between the conventional and valve-less trocar groups.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Prostate Cancer</condition>
  <condition>Pneumoperitoneum</condition>
  <arm_group>
    <arm_group_label>AirSeal System</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group receives the AirSeal System for intraoperative insufflation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Endopath</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group receives the Standard Endopath Trocar for intraoperative insufflation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AirSeal System</intervention_name>
    <description>To analyze the results of patients randomized to either the AirSeal system or Standard Endopath trocar.</description>
    <arm_group_label>AirSeal System</arm_group_label>
    <other_name>Valve-free Trocar</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Standard Endopath</intervention_name>
    <description>This group receives the Standard Endopath  Trocar for intraoperative insufflation.</description>
    <arm_group_label>Standard Endopath</arm_group_label>
    <other_name>Endopath Trocar</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age&gt;18

          -  Eligible and elect to undergo robotic prostatectomy surgery @ OhioHealth Dublin
             Methodist Hospital

        Exclusion Criteria:

          -  Age &lt; 18

          -  Emergency surgery

          -  Ascites

          -  BMI&gt;44 or &lt;18
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ronney Abaza, MD,FACS</last_name>
    <role>Principal Investigator</role>
    <affiliation>OhioHealth</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Janice L Rosenthal, RN</last_name>
    <phone>614-544-8430</phone>
    <email>janice.rosenthal@ohiohealth.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tamara L McMath, MPH</last_name>
    <phone>614-566-5548</phone>
    <email>tamara.mcmath@ohiohealth.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Dublin Methodist Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Janice L Rosenthal, RN</last_name>
      <phone>614-544-8430</phone>
      <email>janice.rosenthal@ohiohealth.com</email>
    </contact>
    <contact_backup>
      <last_name>Tamara L McMath, MPH</last_name>
      <phone>614-566-5548</phone>
      <email>tamara.mcmath@ohiohealth.com</email>
    </contact_backup>
    <investigator>
      <last_name>Ronney Abaza, MD,FACS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 11, 2014</lastchanged_date>
  <firstreceived_date>January 10, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>OhioHealth</investigator_affiliation>
    <investigator_full_name>Ronney Abaza</investigator_full_name>
    <investigator_title>Medical Director Robotic Surgery</investigator_title>
  </responsible_party>
  <keyword>AirSeal</keyword>
  <keyword>Trocar</keyword>
  <keyword>Carbon Dioxide Exchange and Absorption</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pneumoperitoneum</mesh_term>
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
